What is the initial management for spinal cord causes of flexion contracture and spasticity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Management of Spinal Cord-Related Flexion Contracture and Spasticity

For spinal cord injury patients with flexion contractures and spasticity, begin immediately with range-of-motion exercises, positioning, and stretching, then add oral baclofen (starting at 5 mg three times daily) as first-line pharmacological therapy, specifically targeting flexor spasms and muscular rigidity. 1, 2, 3, 4

Non-Pharmacological Interventions (First-Line)

The initial approach must prioritize physical modalities before medications:

  • Range-of-motion exercises should be initiated immediately to prevent contracture progression 1, 5
  • Antispastic positioning and proper body alignment reduce reflex hyperexcitability 1, 5
  • Stretching programs and splinting help maintain joint mobility and prevent fixed contractures 1, 5
  • Serial casting may be necessary for established contractures 5

These interventions address the underlying pathophysiology—spasticity represents a hyper-excitable state of spinal reflex arcs below the injury level, affecting skeletal motor systems 6

Pharmacological Management Algorithm

First-Line Oral Medication: Baclofen

Baclofen is FDA-approved specifically for spasticity from spinal cord injuries and is particularly effective for flexor spasms and concomitant pain 3, 4:

  • Starting dose: 5 mg three times daily 2
  • Titration: Increase gradually; older patients rarely tolerate >30-40 mg/day 2
  • Mechanism: GABA-B agonist that reduces spinal reflex hyperexcitability 2, 7
  • Target symptoms: Flexor spasms, muscular rigidity, and pain associated with spasticity 3, 4, 7

Alternative Oral Agents

If baclofen is not tolerated or contraindicated:

  • Tizanidine: Start 2 mg three times daily; centrally acting alpha-2 adrenergic agonist 2, 8
  • Dantrolene: Acts directly on skeletal muscle; carries black box warning for hepatotoxicity (0.1-0.2% risk) 2

Avoid benzodiazepines (diazepam) during recovery phases as they may negatively impact neurological recovery 1, 2, 5

Critical Monitoring Requirements

When initiating baclofen therapy, monitor closely for:

  • Muscle weakness that could impair residual function 2
  • Urinary function changes 2
  • Cognitive effects and sedation 2
  • Never abruptly discontinue—can cause severe CNS withdrawal symptoms 2

When to Escalate Treatment

For Focal Spasticity

If specific muscle groups remain problematic despite oral medications:

  • Botulinum toxin injections target specific muscles causing contracture 1, 5
  • Phenol nerve blocks for localized muscle groups 1

For Severe, Refractory Spasticity

When oral medications fail at maximum tolerated doses:

  • Intrathecal baclofen via programmable pump delivers drug directly to spinal cord 1, 2, 9, 10
  • Doses range 21-500 mcg/24 hours (mean 160 mcg/24 hours) 9
  • Reduces muscle tone from Ashworth score 4.0 to 1.2 and maintains long-term control 10
  • Requires careful dose titration to avoid overdose complications 9

Surgical Options (Last Resort)

Only consider after all conservative measures fail:

  • Selective longitudinal myelotomy is preferred over destructive procedures 6
  • Tendon lengthening/release for fixed contractures after spasticity control 6, 11
  • Avoid destructive procedures (rhizotomies, cordectomies) as they are too invasive 6

Critical Pitfall: Identifying Underlying Causes

Excessive spasticity should be treated as a pain equivalent in spinal cord injury patients 6:

  • Search for triggering conditions: urinary tract infections, fecal impaction, pressure ulcers, calculi 1, 6
  • These normally painful conditions trigger hyper-sensitive reflexes, worsening spasticity 6
  • Treating the underlying condition often reduces spasticity more effectively than increasing medications 6

Timeline Expectations

  • Spasticity emerges 1-2 months post-injury from initial spinal shock 6
  • Usually plateaus at mild-to-moderate levels by 3-4 months 6
  • Excessive spasticity beyond this timeline warrants investigation for secondary causes 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tizanidine vs Baclofen for Muscle Spasticity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Managing Post-Stroke Spasticity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Spasticity following spinal cord injury.

Clinical orthopaedics and related research, 1975

Research

Intrathecal baclofen for severe spinal spasticity.

The New England journal of medicine, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.